Event-Driven Stocks

GENVEC INC

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

Signs1 good5 warning2 severedetails ↓

Financials

SEC XBRL · annual
 FY16FY15FY14FY13FY12FY11
Revenue$290,000$405,000$2.1M$1.2M$3.2M$5.3M
Operating income−$1.9M−$1.5M−$964,000−$3.1M−$3.2M−$2.2M
Net income−$1.9M−$1.5M−$963,000−$3.0M−$3.2M−$2.2M
Total assets$7.7M$9.5M$15.6M$7.3M$17.4M$30.1M
Total liabilities$3.0M$1.8M$2.3M$2.6M$3.7M$3.6M
Equity$4.7M$7.7M$13.3M$4.6M$13.7M$26.5M
EPS (diluted)
Shares out.17.3M17.3M17.3M12.9M13.0M13.0M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2016
Operating margin
−641.0%
Net margin
−641.4%
Return on equity
−39.5%
Return on assets
−24.1%
Return on capital (ROCE)
−31.7%
Liabilities / assets
39.0%
Debt / equity
0.64×
Book value / share
$0.27
Revenue growth (YoY)
−28.4%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2016
Altman Z″ (distress)
-118.13distress
Accruals / assets
53.5%high accruals
Piotroski F-Score
1/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
22
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 0Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

2 severe5 warning1 good
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Conservative leverage (liabilities < 50% of assets)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.